Barry Andrews (1944–2021)On 10 January 2022, Barry Andrews CBE, FRPharmS, aged 77 years, of West Horsley, Surrey. Mr Andrews registered with the Society in 1966 and was made a Fellow in 1997.…
World Health Organization recommends JAK inhibitor for treatment of severe or critical COVID-19 The monoclonal antibody sotrovimab has also been conditionally recommended for treating mild or moderate COVID-19 in patients who are at high risk of hospitalisation.…
How we introduced electronic prescribing during the COVID-19 pandemic Rushika Patel explains how one of the UK's largest hospitals managed risk and rapidly changing clinical guidance to implement an electronic prescribing and medicines administration system.…
Community pharmacies to supply antiviral treatments to high-risk COVID-19 patients Scottish community pharmacies will be able to dispense the antiviral molnupiravir to patients at high risk of severe illness or death from COVID-19.…
Quarter of referrals under national hospital discharge service from just one area Exclusive: More than a quarter of the 63,109 referrals within the first nine months of the discharge medicine service were sent from NHS trusts in the Cheshire and Merseyside Sustainability and Transformation Partnership area.…
Community pharmacies administer 22 million COVID-19 vaccines in a year A total of 1,500 pharmacy-led vaccination sites have delivered nearly 20% of all COVID-19 vaccinations since the programme began.…
Long service of membersThe Pharmaceutical Journal is marking long service of members by publishing the names of Members and Fellows of the Royal Pharmaceutical Society who reached 50, 60 or 70 years of continuous membership in 2021. Members wishing to have their contact details forwarded to any of these people should a…
Trainees to use new online platform for pharmacy registration exam in 2022 The General Pharmaceutical Council plans to run the registration assessment online until at least 2024.…
Gene therapy: from catastrophe to cure in 20 years After several setbacks since its inception over 30 years ago, in vivo gene therapy is starting to make some significant headway, with new therapies being developed across various therapeutic areas, from ophthalmology to oncology.…
MHRA to launch consultation on changes to clinical trial legislation Proposed changes to the legislation will aim to “streamline” clinical trials approvals, promote public involvement and enhance transparency.…
